B and VIIT Eye Center

411 Seocho-daero, Seocho 4(sa)-dong, Seocho-gu, Seoul, South Korea

Total review: 8

Est. 1994

Implantable Contact Lens (ICL)

Starting from $3,700,000

B and VIIT Eye Center

411 Seocho-daero, Seocho 4(sa)-dong, Seocho-gu, Seoul, South Korea

Total review: 8

Established

1994

Highlights at B and VIIT Eye Center

Map View

Click to explore
Reviews (8)

5.0
Accreditations
Languages spoken
- Chinese
- English
- Korean

Implantable Contact Lens (ICL) at B and VIIT Eye Center

B and VIIT Eye Center, can be found in Dogok dong, Seoul, South Korea and offers its patients Implantable Contact Lens (ICL) procedures as well as 6 other procedures, across 1 different procedure categories

. The price of a Implantable Contact Lens (ICL) procedure varies from ₩3,700,000 to ₩5,700,000, and the average price is around ₩3,505.

Many medical professionals work at the Clinic, with 58 in total, and B and VIIT Eye Center has several accreditations, including:

ESCRS - European Society of Cataract and Refractive Surgeons
APAO - Asia Pacific Academy of Ophthalmology

Facility Services Available at B and VIIT Eye Center

Cafe

Free Wifi

Hotel booking

Interpreter services

Parking available

Pharmacy

Restaurant

Safe in the room

Translation services

TV in the room

WHY US?

At Medijump, we're making medical easy. You can search, compare, discuss, and book your medical all in one place. We open the door to the best medical providers worldwide, saving you time and energy along the way, and it's all for FREE, no hidden fees, and no price markups guaranteed. So what are you waiting for?

Free

Best Price

Widest Selection

Risk-Free

What you need to know about Implantable Contact Lens (ICL) in Seoul

An implantable contact lens (ICL) is a special contact lens that is implanted inside the eye and works with the eye’s natural lens. Unlike regular contact lenses, ICL does not need frequent removal. It can correct a wide range of vision errors, including nearsightedness (myopia), farsightedness (hyperopia), and astigmatism. ICL is made from a material called Collamer, which is safe to stay in the eye for a long period of time.

The lens can be customized according to the patient’s eye shape and size, and it can be removed if your prescription does change over time. ICL is a possible solution for people who are not ideal to undergo LASIK or those who do not like the idea of permanently removing their corneal tissue.

What's the Recovery Time for Implantable Contact Lens (ICL) Procedures in Seoul?

The recovery time after ICL is relatively short. While your eye will be completely healed within a month or two, you should see the result within 24 hours. It is recommended that you take at least 5 to 7 days off work and avoid any vigorous activity. Your surgeon will discuss the recovery timeline in detail with you.

Despite the surgery being fairly swift, typically lasting less than half an hour for both eyes, the post-surgery phase holds significant importance for complete healing. Routine check-ups post-procedure are essential to track the healing progression and ascertain ideal outcomes. A rigorous care routine post-surgery is crucial to expedite recuperation.

What's the Success Rate of Implantable Contact Lens (ICL) Procedures in Seoul?

Before being placed on the market, ICL was subject to extensive research and development. Today, it is an effective, safe, and highly successful procedure, with about 99% of patients who had it claimed to be satisfied with their implants.

Multiple scientific research and testimonials shared by patients accentuate the effectiveness of the Implantable Contact Lens operation, as the majority of patients reach at least 20/40 vision, which is a common legal requirement for driving. Moreover, this operation is recognized for its high safety standards, coupled with a minuscule complication rate.

However, similar to all medical interventions, the results of the Implantable Contact Lens (ICL) can fluctuate amongst different individuals. This can be due to several contributors such as the refractive error magnitude, the total eye health of the patient, and the adherence to post-operation guidelines. It is worth acknowledging that although the Implantable Contact Lens (ICL) has demonstrated significant effectiveness, it doesn’t act as a deterrent against age-oriented eye disorders such as cataracts or macular degeneration.